Intuitive Surgical executives today said delays and price increases are working their way through the medtech supply chain, likely resulting in higher production costs in the months ahead and the potential for delayed development and regulatory activity. “I don’t think I can say it’s getting better. it’s a difficult situation and will continue for some […]
Surgical
Intuitive Surgical names new C-suite leaders, reports Street-beating Q3
Intuitive Surgical (NSDQ:ISRG) today announced changes in the ranks of its senior leadership as the surgical robotics maker released Q3 results that exceeded expectations. Sunnyvale, California-based Intuitive launched two new functional organizations — Strategy and Growth, and Global Business Services — and named leaders who will take over effective Jan. 1. Get the full story […]
Johnson & Johnson discloses two-year delay for Ottava robot
Johnson & Johnson (NYSE:JNJ) today confirmed that it experienced a “temporary setback” with its Ottava surgical robotic system. Speaking on the company’s third-quarter earnings call, transcribed by SeekingAlpha, J&J EVP Joseph Wolk said that, while the company maintains its commitment to developing a general surgery offering with Ottava, the platform’s development timeline has been pushed […]
Forecasting the future of urology with Boston Scientific’s Meghan Scanlon
Meghan Scanlon, Boston Scientific’s president of urology and pelvic health, discusses the field and the challenges and opportunities ahead. The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field, said Meghan Scanlon, SVP and president of urology and pelvic health at Boston Scientific (NYSE:BSX) That […]
Hologic plans to buy Bolder Surgical for $160M
Hologic Inc. (NSDQ:HOLX) said today that it has a $160 million deal to acquire Bolder Surgical, a developer and manufacturer of advanced energy vessel-sealing surgical devices. Louisville, Colorado–based Bolder Surgical’s laparoscopic vessel sealing, dividing and dissecting devices will join Hologic’s surgical portfolio when the deal closes, expected by the end of 2021. Marlborough, Massachusetts–based Hologic […]
OneProjects raises $17M to advance 4D cardiac imaging
Irish-German cardiac imaging startup OneProjects today announced $8 million in Series A2 funding and two grants totaling $9 million. The company will use the new funds to complete product development, conduct clinical trials, gain FDA clearance and prepare for U.S. commercialization of the first product developed from its proprietary 4D cardiac imaging platform, Verafeye. Get […]
Medtronic’s Hugo robotic-assisted surgical system wins regulatory nod in Europe
Medtronic (NYSE:MDT) announced that it received CE mark approval in Europe for its Hugo robotic-assisted surgery system. Fridley, Minnesota-based Medtronic’s CE mark covers urologic and gynecologic procedures, which make up approximately half of all robotic procedures performed today, according to a news release. Last month, the company said it had been expecting to receive such […]
Asensus Surgical’s board chair is leaving
Asensus Surgical (NYSE:ASXC) announced that Paul LaViolette, the company’s board chair, will step down from his position. LaViolette, who has served as the chair of the board since 2013, will step down as chair later this month and intends to leave the board before the end of the year due to other professional commitments. According […]
Activ Surgical closes $45M Series B funding round
Activ Surgical today announced that it has secured $45 million in a Series B funding round. The funding round was led by Cota Capital and included seven new investors. To date, the Boston-based company has raised a total of $77 million. Activ Surgical is developing a hardware-agnostic platform with ActivInsights augmented reality-based software for autonomous […]
Hologic expands Omni hysteroscopy offering in Europe
Hologic (Nasdaq: HOLX) announced today that it has expanded its Omni suite of gynecological surgical offerings in Europe, Africa and western Asia. The Omni expansion gives physicians greater flexibility and choice as they optimize diagnostic and operative hysteroscopy, according to the Marlborough, Massachusetts–based women’s health company. “The option to ‘see and treat’ is becoming more […]
Vicarious Surgical stock continues to rise
It’s so far, so good for Vicarious Surgical (NYSE:RBOT) during its first week of trading as a public company. The robotic surgery company’s shares were up more than 19% to $15.05 by midday today. During the company’s first day of trading yesterday, shares rose 2% to $12.60 apiece, even as the Dow Jones Industrial Average […]